triazoles has been researched along with Hepatocellular Carcinoma in 54 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (5.56) | 18.7374 |
| 1990's | 1 (1.85) | 18.2507 |
| 2000's | 8 (14.81) | 29.6817 |
| 2010's | 30 (55.56) | 24.3611 |
| 2020's | 12 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, W; Jiang, Y; Kong, D; Liu, H; Miao, X; Wu, Z | 1 |
| Alotaibi, H; Argundogan, A; Batur, T; Keles, U; Mutlu, Z; Ozturk, M; Senturk, S | 1 |
| An, GY; Baek, M; Binas, B; Chai, JC; Chai, YG; Choi, HI; Jung, KH; Lee, YS; Yoo, E | 1 |
| Koestler, DC; Ly, T; Pei, D; Sardiu, ME; Thompson, JA; Welch, DR; Yellapu, NK | 1 |
| Bhattacharya, D; Buckley, D; Crowley, R; Duke, G; Friedman, SL; Kemble, G; Martins, EB; O'Farrell, M | 1 |
| Charoensuksai, P; Chuaypen, N; Limpachayaporn, P; Nuchpun, S; Sirirak, J; Suksamrarn, A; Tangkijvanich, P; Wongprayoon, P | 1 |
| Abdouni, A; Allende, DS; Apte, SS; Arechederra, M; Audebert, S; Bazai, SK; Daian, F; Dono, R; Gregoire, D; Hibner, U; Lozano, A; Maina, F; Mead, TJ; Richelme, S; Sequera, C | 1 |
| Braeuning, A; Lasch, A; Lichtenstein, D; Marx-Stoelting, P | 1 |
| Abdelhafeez, DA; Aly, OM; Mustafa, M; Nofal, AE; Shatla, IM | 1 |
| Depping, R; Dunst, J; Kosyna, FK; Landesman, Y; Mandl, M; von Fallois, M | 1 |
| Bugide, S; Green, MR; Gupta, R; Wajapeyee, N | 1 |
| Huang, CF; Liu, HS; Ramesh, C; Su, CL; Tseng, CL; Yao, CF | 1 |
| Calvisi, DF; Chen, X; Cigliano, A; Jia, J; Liu, X; Pilo, MG; Qiao, Y; Shao, Z | 1 |
| Guo, WZ; Li, GQ; Li, J; Lv, JF; Zhang, HP; Zhang, JK; Zhang, SJ; Zhang, Y | 1 |
| Bian, CB; Fuchs, BC; Higashi, T; Hirschfield, H; Hoshida, Y; Nair, VD; Nakagawa, S; Zeleke, TZ | 1 |
| Cast, A; D'Souza, AM; Jiang, Y; Karns, R; Kumbaji, M; Lewis, K; Shah, S; Shin, S; Smithrud, D; Timchenko, N; Valanejad, L; Wright, M | 1 |
| Geng, P; Liu, Y; Qin, J; Sun, M; Sun, X; Wu, C; Wu, Y; Yin, Y; Zhan, X; Zhang, S; Zhuang, Z | 1 |
| Braeuning, A; Buhrke, T; Knebel, C; Lampen, A; Marx-Stoelting, P; Süssmuth, R | 1 |
| Boechat, N | 1 |
| Edling, CE; Falasca, M; Ghonaim, R; Maffucci, T; Selvaggi, F | 1 |
| Breitenstein, S; Clavien, PA; Dutkowski, P; Flury, S; Kaiser, P; Maggio, EM; Misselwitz, B; Mueller, NJ; Müllhaupt, B; Pfammatter, T; Schneider, PM | 1 |
| Baraldi, PG; Basso, G; Bertolasi, V; Brancale, A; Cancellieri, M; Castagliuolo, I; Consolaro, F; Hamel, E; Porcù, E; Prencipe, F; Romagnoli, R; Salvador, MK; Viola, G | 1 |
| Gery, S; Kauffman, M; Koeffler, HP; Shacham, S; Sun, H; Zheng, Y | 1 |
| Abrams, TA; Blaszkowsky, LS; Chen, J; Goyal, L; Karol, MD; McCleary, NJ; Sheehan, S; Sundaram, E; Wadlow, RC; Wolpin, BM; Zhu, AX | 1 |
| Ali Alharbi, S; Ananda, H; Baburajeev, CP; Bender, A; Chinnathambi, A; Dhananjaya Mohan, C; Fuchs, JE; Girish, KS; Jagadish, S; Li, F; Rangappa, KS; Rangappa, S; Sethi, G; Sivaraman Siveen, K; Zayed, ME; Zhang, J | 1 |
| Kim, JS; Kim, MJ; Lim, W; Nam, JS; Park, SA; Park, SY; Yhong Sheen, Y | 1 |
| Guo, WZ; Li, GQ; Li, J; Li, SS; Ma, XX; Seng, JJ; Tang, HW; Wang, LD; Yan, B; Zhang, G; Zhang, HP; Zhang, SJ; Zhang, Y | 1 |
| Hai, L; He, Y; Li, X; Wu, Y; Zhang, T | 1 |
| Junyan, P; Shujuan, Y; Shulin, G; Xia, X; Yan, C | 1 |
| Choi, SK; Choi, WS; Eun, JW; Han, JW; Hong, SH; Nam, SW; Shen, Q; You, JS | 1 |
| Caenepeel, S; Coxon, A; Du, Z; He, Y; Hu, L; Huang, E; Huang, J; Rex, K; Shen, Y; Tang, ET; Wang, O; Zhang, M; Zhang, Y; Zhong, W; Zhou, H | 1 |
| Cao, Y; Deng, M; Ding, ZB; Duan, M; Fan, J; Gao, Q; Liang, CM; Lin, YH; Liu, LZ; Niu, G; Shi, JY; Shi, YY; Wang, XY; Wang, ZC; Worthley, DL; Xi, R; Xia, Y; Xiong, L; Yang, LX; Zhang, S; Zhou, J; Zhou, XY | 1 |
| Fujisawa, K; Hidaka, I; Ishikawa, T; Iwamoto, T; Maeda, M; Matsumoto, T; Saeki, I; Sakaida, I; Takami, T; Tani, K; Uchida, K; Yamamoto, N; Yamasaki, T | 1 |
| Hester, SD; Moore, T; Nesnow, S; Ren, H; Ward, W | 1 |
| Brissot, P; Cannie, I; Gaboriau, F; Gouffier, L; Leray, AM; Lescoat, G; Loréal, O; Ropert, M; Troadec, MB | 1 |
| Clément, S; Conzelmann, S; Gonelle-Gispert, C; Guilloux, K; Negro, F; Pascarella, S | 1 |
| Hsu, CI; Hsu, MH; Huang, RC; Hwu, JR; Lee, YC; Liang, YC | 1 |
| Aihara, Y; Fukui, H; Ikenaka, Y; Kaji, K; Kawaratani, H; Kitade, M; Namisaki, T; Noguchi, R; Shirai, Y; Tsujimoto, T; Yanase, K; Yoshii, J; Yoshiji, H | 1 |
| Aguiar, AC; Bastos, MM; Bezerra, FA; Boechat, N; Camilo, AL; Costa, CC; da Silva, GP; da Silva, NV; de C da Silva, F; de Lourdes G Ferreira, M; Dos S Costa, M; Ferreira, SB; Ferreira, VF; Krettli, AU; Lourenço, MC; Martins, PR; Pinto, AC; Teixeira, BM | 1 |
| Li, D; Li, G; Liu, G; Lu, J; Ma, X; Wang, Y; Wu, Y; Zhang, S; Zhao, Y | 1 |
| Dufty, NE; Else, LJ; Gilleran, G; Hawkins, D; Taylor, S | 1 |
| Blanco, JR; Martínez, A; Ochoa-Callejero, L; Oteo, JA; Pérez-Martínez, L; Rubio-Mediavilla, S | 1 |
| Capiod, T; Colosetti, P; Enfissi, A; Prigent, S | 1 |
| Fang, RY; He, QJ; Lou, YJ; Yang, B; Zhu, DY | 1 |
| Brissot, P; Chantrel-Groussard, K; Gaboriau, F; Havouis, R; Lescoat, G; Nick, H; Pasdeloup, N; Pierre, JL | 1 |
| Dassonville, A; Desplat, V; Gaboriau, F; Guillon, J; Jarry, C; Lescoat, G; Nascimento, S; Pires, VS; Rochette, J; Sonnet, P | 1 |
| Brissot, P; Chantrel-Groussard, K; Gaboriau, F; Lescoat, G; Nick, H; Pasdeloup, N | 1 |
| Li, D; Ma, CP; Qu, B; Sun, LH; Wan, J; Wang, W; Zhang, HQ; Zhang, SS | 1 |
| Harada, N; Hatano, O | 1 |
| Brookins, J; Fisher, JW | 1 |
| Hruban, Z; Morris, HP; Rechcigl, M | 1 |
| Vasil'eva, NN | 1 |
| Higashi, T; Kashiwagi, K; Tobe, T | 1 |
1 review(s) available for triazoles and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
3 trial(s) available for triazoles and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide | 2023 |
A phase I and pharmacokinetic study of ganetespib (STA-9090) in advanced hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; HSP90 Heat-Shock Proteins; Humans; Liver; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Treatment Outcome; Triazoles | 2015 |
Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Animals; Benzoates; Carcinoma, Hepatocellular; Deferasirox; Drug Screening Assays, Antitumor; Female; Hep G2 Cells; Humans; Iron Chelating Agents; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Middle Aged; Triazoles | 2016 |
51 other study(ies) available for triazoles and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Tadalafil enhances the therapeutic efficacy of BET inhibitors in hepatocellular carcinoma through activating Hippo pathway.
Topics: Animals; Azepines; Carcinoma, Hepatocellular; Cyclic Nucleotide Phosphodiesterases, Type 5; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Hippo Signaling Pathway; Humans; Liver Neoplasms; Mice; Nerve Tissue Proteins; Phosphodiesterase 5 Inhibitors; Proto-Oncogene Proteins c-myc; Receptors, Cell Surface; Tadalafil; Triazoles; YAP-Signaling Proteins | 2021 |
AXL Knock-Out in SNU475 Hepatocellular Carcinoma Cells Provides Evidence for Lethal Effect Associated with G2 Arrest and Polyploidization.
Topics: Animals; Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; CRISPR-Cas Systems; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Gene Knockout Techniques; Humans; Liver Neoplasms; Male; Mice; Neoplasm Transplantation; Phenotype; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Triazoles; Up-Regulation | 2021 |
The bromodomain inhibitor JQ1 up-regulates the long non-coding RNA MALAT1 in cultured human hepatic carcinoma cells.
Topics: Azepines; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Chromatin; Humans; Liver Neoplasms; Nuclear Proteins; RNA, Long Noncoding; Transcription Factors; Triazoles | 2022 |
Synergistic anti-proliferative activity of JQ1 and GSK2801 in triple-negative breast cancer.
Topics: Azepines; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cysteine Endopeptidases; Gene Expression Regulation, Neoplastic; Humans; Indolizines; Kisspeptins; Liver Neoplasms; Phosphatidylinositol 3-Kinases; Scavenger Receptors, Class A; Sulfones; Triazoles; Triple Negative Breast Neoplasms | 2022 |
FASN inhibition targets multiple drivers of NASH by reducing steatosis, inflammation and fibrosis in preclinical models.
Topics: Actins; Animals; Carcinoma, Hepatocellular; Cytokines; Disease Models, Animal; Fatty Acid Synthase, Type I; Fatty Acid Synthases; Humans; Inflammation; Lipopolysaccharides; Liver Cirrhosis; Liver Neoplasms; Mice; Nitriles; Non-alcoholic Fatty Liver Disease; Piperidines; Triazoles; Triglycerides | 2022 |
meta-Ureidophenoxy-1,2,3-triazole hybrid as a novel scaffold for promising HepG2 hepatocellular carcinoma inhibitors: Synthesis, biological evaluation and molecular docking studies.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Humans; Liver Neoplasms; Molecular Docking Simulation; Molecular Structure; Sorafenib; Structure-Activity Relationship; Triazoles; Vascular Endothelial Growth Factor Receptor-2 | 2022 |
ADAMTSL5 is an epigenetically activated gene underlying tumorigenesis and drug resistance in hepatocellular carcinoma.
Topics: ADAMTS Proteins; ADAMTS5 Protein; Animals; Antineoplastic Agents, Immunological; Benzocycloheptenes; Carcinogenesis; Carcinoma, Hepatocellular; Drug Resistance, Neoplasm; Epigenomics; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Mice; Phenylurea Compounds; Quinolines; Signal Transduction; Sorafenib; Transcriptional Activation; Triazoles; Tumor Microenvironment | 2021 |
More than additive effects on liver triglyceride accumulation by combinations of steatotic and non-steatotic pesticides in HepaRG cells.
Topics: Adverse Outcome Pathways; Carcinoma, Hepatocellular; Cell Line, Tumor; Dioxolanes; Dioxoles; Fatty Acids; Fatty Liver; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Models, Theoretical; Pesticides; Pyrroles; Triazoles; Triglycerides | 2021 |
OMA1520 and OMA1774, novel 1,2,4-triazole bearing analogs of combretastatin A-4, inhibit hepatocellular carcinoma: Histological and immunohistochemical studies.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Carcinoma, Hepatocellular; Hep G2 Cells; HL-60 Cells; Humans; Liver Neoplasms, Experimental; Male; MCF-7 Cells; Molecular Docking Simulation; Rats; Triazoles | 2021 |
Selinexor decreases HIF-1α via inhibition of CRM1 in human osteosarcoma and hepatoma cells associated with an increased radiosensitivity.
Topics: Apoptosis; Bone Neoplasms; Carcinoma, Hepatocellular; Cell Proliferation; Exportin 1 Protein; Gene Expression Regulation, Neoplastic; Humans; Hydrazines; Hypoxia-Inducible Factor 1, alpha Subunit; Karyopherins; Liver Neoplasms; Osteosarcoma; Radiation Tolerance; Radiation-Sensitizing Agents; Receptors, Cytoplasmic and Nuclear; Triazoles; Tumor Cells, Cultured | 2021 |
EZH2 inhibits NK cell-mediated antitumor immunity by suppressing CXCL10 expression in an HDAC10-dependent manner.
Topics: Animals; Benzopyrans; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Chemokine CXCL10; Chemokines; Decitabine; Enhancer of Zeste Homolog 2 Protein; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Histone Deacetylases; Humans; Indazoles; Indoles; Killer Cells, Natural; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Phenols; Pyridones; Sulfones; Triazoles | 2021 |
Using gene expression database to uncover biology functions of 1,4-disubstituted 1,2,3-triazole analogues synthesized via a copper (I)-catalyzed reaction.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Carcinoma, Hepatocellular; Cell Line, Tumor; Copper; Curcumin; Databases, Genetic; Glycogen Synthase Kinase 3; Humans; Liver Neoplasms; Structure-Activity Relationship; Thiazoles; Triazoles; Urea | 2017 |
Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade.
Topics: Adaptor Proteins, Signal Transducing; Angiomotins; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Heterocyclic Compounds, 3-Ring; Humans; Liver Neoplasms; Membrane Proteins; Phosphoproteins; Real-Time Polymerase Chain Reaction; Sulfones; Tankyrases; Transcription Factors; Triazoles; YAP-Signaling Proteins | 2017 |
Upregulation of Mcl-1 inhibits JQ1-triggered anticancer activity in hepatocellular carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Azepines; Carcinoma, Hepatocellular; Cell Line, Tumor; Hep G2 Cells; Humans; Liver Neoplasms; Myeloid Cell Leukemia Sequence 1 Protein; Proteins; Triazoles; Up-Regulation | 2018 |
In vitro modeling of hepatocellular carcinoma molecular subtypes for anti-cancer drug assessment.
Topics: alpha-Fetoproteins; Antineoplastic Agents; Azepines; beta Catenin; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Screening Assays, Antitumor; Gene Expression Profiling; Humans; Liver Neoplasms; Molecular Targeted Therapy; Triazoles | 2018 |
Gankyrin Promotes Tumor-Suppressor Protein Degradation to Drive Hepatocyte Proliferation.
Topics: Animals; Benzenesulfonates; Carbon Tetrachloride; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Hepatoblastoma; Hepatocytes; Humans; Liver Neoplasms; Male; Mice; Mice, Knockout; Transcription Factors; Triazoles; Tumor Suppressor Proteins | 2018 |
EGFR signaling confers resistance to BET inhibition in hepatocellular carcinoma through stabilizing oncogenic MYC.
Topics: Animals; Antineoplastic Agents; Azepines; Carcinoma, Hepatocellular; Drug Resistance, Neoplasm; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Humans; Liver Neoplasms; Mice; Proteins; Proto-Oncogene Proteins c-myc; Signal Transduction; Sorafenib; Triazoles; Xenograft Model Antitumor Assays | 2019 |
Pregnane X receptor mediates steatotic effects of propiconazole and tebuconazole in human liver cell lines.
Topics: Carcinoma, Hepatocellular; Cell Line; Fatty Liver; Fungicides, Industrial; Gene Knockout Techniques; Hep G2 Cells; Humans; Liver Neoplasms; Pregnane X Receptor; Triazoles | 2019 |
Editorial: new developments in the search for agents to treat tuberculosis.
Topics: Antitubercular Agents; Carcinoma, Hepatocellular; Cell Proliferation; Humans; Isoniazid; Liver Neoplasms; Mycobacterium tuberculosis; Triazoles | 2013 |
Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway.
Topics: Antineoplastic Agents; Apoptosis; Caffeine; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Humans; Liver Neoplasms; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Purinergic P1 Receptor Agonists; Quinazolines; Signal Transduction; Triazoles | 2014 |
Histopathological evidence of invasive gastric mucormycosis after transarterial chemoembolization and liver transplantation.
Topics: Amphotericin B; Antifungal Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Diabetes Complications; Female; Hepatitis B, Chronic; Histocytochemistry; Humans; Immunocompromised Host; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Microscopy; Middle Aged; Mucorales; Mucormycosis; Stomach Diseases; Triazoles | 2014 |
Synthesis, antimitotic and antivascular activity of 1-(3',4',5'-trimethoxybenzoyl)-3-arylamino-5-amino-1,2,4-triazoles.
Topics: Angiogenesis Inhibitors; Aniline Compounds; Animals; Antimitotic Agents; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Colchicine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Human Umbilical Vein Endothelial Cells; Humans; Liver Neoplasms; Mice, Inbred BALB C; Models, Molecular; Neoplasm Transplantation; Neoplastic Stem Cells; Protein Binding; Stereoisomerism; Structure-Activity Relationship; Triazines; Triazoles; Tubulin; Tubulin Modulators | 2014 |
KPT-330 inhibitor of XPO1-mediated nuclear export has anti-proliferative activity in hepatocellular carcinoma.
Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Exportin 1 Protein; Female; Humans; Hydrazines; Karyopherins; Liver Neoplasms; Mice; Mice, Nude; Oncogene Proteins; Proto-Oncogene Proteins; Receptors, Cytoplasmic and Nuclear; Triazoles; Xenograft Model Antitumor Assays | 2014 |
Development of Novel Triazolo-Thiadiazoles from Heterogeneous "Green" Catalysis as Protein Tyrosine Phosphatase 1B Inhibitors.
Topics: Animals; Antineoplastic Agents; Benzofurans; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Caspase 3; Cell Line, Tumor; Cell Movement; Chromones; Cyclin D1; Disease Models, Animal; Dose-Response Relationship, Drug; Female; G1 Phase Cell Cycle Checkpoints; Hep G2 Cells; Human Umbilical Vein Endothelial Cells; Humans; Inhibitor of Apoptosis Proteins; Liver Neoplasms; Mice; Models, Molecular; Neoplasm Invasiveness; Neovascularization, Pathologic; Poly(ADP-ribose) Polymerases; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; STAT3 Transcription Factor; Structure-Activity Relationship; Survivin; Thiadiazoles; Triazoles | 2015 |
TIMP-1 mediates TGF-β-dependent crosstalk between hepatic stellate and cancer cells via FAK signaling.
Topics: Aniline Compounds; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Communication; Cell Line, Transformed; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Disease Progression; Epithelial-Mesenchymal Transition; Female; Focal Adhesion Protein-Tyrosine Kinases; Hepatic Stellate Cells; Heterografts; Humans; Liver Neoplasms; Mice; Proto-Oncogene Proteins c-akt; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta; Triazoles | 2015 |
Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression.
Topics: Animals; Apoptosis; Azepines; Bcl-2-Like Protein 11; Blotting, Western; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Proliferation; Chromatin Immunoprecipitation; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Liver Neoplasms; Mice; Nuclear Proteins; Proto-Oncogene Proteins c-myc; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Transcription Factors; Triazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2016 |
A Novel Method to Synthesize 4-Aryl-1H-1,2,3-Triazoles and its Antihepatoma Activity.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Liver Neoplasms; Molecular Structure; Structure-Activity Relationship; Triazoles | 2016 |
The Antitumor Effect of DYC-279 on Human Hepatocellular Carcinoma HepG2 Cells.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; CDC2 Protein Kinase; Cell Proliferation; Cell Survival; Cyclin B1; Cyclin D1; Cyclin-Dependent Kinases; Cytochromes c; Hep G2 Cells; Humans; Liver Neoplasms; Piperazines; Proto-Oncogene Proteins c-bcl-2; Triazoles | 2016 |
Epigenetic reader BRD4 inhibition as a therapeutic strategy to suppress E2F2-cell cycle regulation circuit in liver cancer.
Topics: Azepines; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; E2F2 Transcription Factor; Epigenesis, Genetic; Hep G2 Cells; Humans; Liver Neoplasms; Nuclear Proteins; Transcription Factors; Triazoles | 2016 |
Preclinical Evaluation of AMG 337, a Highly Selective Small Molecule MET Inhibitor, in Hepatocellular Carcinoma.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Amplification; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Mice; Proto-Oncogene Proteins c-met; Pyridones; Signal Transduction; Small Molecule Libraries; Triazoles; Xenograft Model Antitumor Assays | 2016 |
Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.
Topics: Antineoplastic Agents; Azepines; Base Sequence; Carcinoma, Hepatocellular; Cell Line, Tumor; Clonal Evolution; DNA Copy Number Variations; DNA Mutational Analysis; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Exome; Fibroblast Growth Factors; Gene Amplification; Genetic Heterogeneity; Humans; Indazoles; Liver Neoplasms; Mutation, Missense; Pharmacogenomic Variants; Phylogeny; Primary Cell Culture; Receptor, Fibroblast Growth Factor, Type 4; RNA, Messenger; Sequence Deletion; Triazoles | 2017 |
Discrimination of tumorigenic triazole conazoles from phenobarbital by transcriptional analyses of mouse liver gene expression.
Topics: Animals; Carcinogens; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Fungicides, Industrial; Gene Expression; Gene Expression Profiling; Hybridization, Genetic; Liver; Male; Mice; Oligonucleotide Array Sequence Analysis; Organ Size; Phenobarbital; Transcription Factors; Transcription, Genetic; Triazoles | 2009 |
Effects of deferasirox and deferiprone on cellular iron load in the human hepatoma cell line HepaRG.
Topics: Benzoates; Carcinoma, Hepatocellular; Cell Line, Tumor; Deferasirox; Deferiprone; Dose-Response Relationship, Drug; Female; Ferritins; Hepatocytes; Humans; Iron; Iron Chelating Agents; Liver Neoplasms; Molecular Structure; Pyridones; Receptors, Transferrin; Triazoles | 2010 |
The hepatitis C virus core protein indirectly induces alpha-smooth muscle actin expression in hepatic stellate cells via interleukin-8.
Topics: Carcinoma, Hepatocellular; Cell Movement; Cloning, Molecular; Developing Countries; DNA Primers; DNA, Complementary; Hepacivirus; Hepatitis C; Humans; Incidence; Interleukin-8; Liver Neoplasms; Phenylurea Compounds; Polymerase Chain Reaction; Receptors, Interleukin-8A; Receptors, Interleukin-8B; RNA, Messenger; RNA, Viral; Triazoles; Tumor Cells, Cultured; Viral Core Proteins | 2010 |
Glycosylated nordihydroguaiaretic acids as anti-cancer agents.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Galactosides; Glucosides; Glycosylation; Humans; Liver Neoplasms; Masoprocol; Triazoles | 2011 |
Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats.
Topics: Administration, Oral; Angiogenesis Inhibitors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzoates; Carcinoma, Hepatocellular; Cell Proliferation; Cells, Cultured; Choline Deficiency; Deferasirox; Disease Progression; Drug Therapy, Combination; Fatty Liver; Hepatic Stellate Cells; Iron Chelating Agents; Liver Cirrhosis, Experimental; Liver Neoplasms, Experimental; Losartan; Male; Neovascularization, Pathologic; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats; Rats, Inbred F344; Time Factors; Transforming Growth Factor beta1; Triazoles | 2011 |
Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain.
Topics: Antitubercular Agents; Carcinoma, Hepatocellular; Cell Proliferation; Click Chemistry; Humans; Isoniazid; Liver Neoplasms; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Triazoles; Tumor Cells, Cultured | 2011 |
Smac mimetic SM-164 potentiates APO2L/TRAIL- and doxorubicin-mediated anticancer activity in human hepatocellular carcinoma cells.
Topics: Antineoplastic Agents; APOBEC Deaminases; Apoptosis; Apoptosis Regulatory Proteins; Biomimetics; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Cytidine Deaminase; Doxorubicin; Humans; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Mitochondrial Proteins; Muscle Proteins; TNF-Related Apoptosis-Inducing Ligand; Triazoles | 2012 |
Pharmacokinetic interaction of maraviroc with tacrolimus in a patient coinfected with HIV and hepatitis B virus following hepatic transplant due to hepatocellular carcinoma.
Topics: Anti-HIV Agents; Carcinoma, Hepatocellular; Cyclohexanes; Drug Interactions; Hepatitis B; HIV Infections; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Maraviroc; Middle Aged; Plasma; Tacrolimus; Treatment Outcome; Triazoles | 2013 |
Maraviroc, a CCR5 antagonist, prevents development of hepatocellular carcinoma in a mouse model.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; CCR5 Receptor Antagonists; Cell Proliferation; Cyclohexanes; Humans; Liver Cirrhosis; MAP Kinase Signaling System; Maraviroc; Mice; Neoplasms, Experimental; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Receptors, CCR5; Triazoles | 2013 |
The blocking of capacitative calcium entry by 2-aminoethyl diphenylborate (2-APB) and carboxyamidotriazole (CAI) inhibits proliferation in Hep G2 and Huh-7 human hepatoma cells.
Topics: Antineoplastic Agents; Boron Compounds; Calcium; Calcium Channel Blockers; Calcium Channels; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Growth Inhibitors; Humans; Liver Neoplasms; Triazoles | 2004 |
Antiproliferative activity of contragestazol (DL111-IT) in murine and human tumor models in vitro and in vivo.
Topics: Animals; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Female; Flow Cytometry; Gene Expression Profiling; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Sarcoma; Transplantation, Heterologous; Triazoles; Tumor Cells, Cultured | 2006 |
The new orally active iron chelator ICL670A exhibits a higher antiproliferative effect in human hepatocyte cultures than O-trensox.
Topics: Acetyltransferases; Apoptosis; Benzoates; Biogenic Polyamines; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Deferasirox; DNA Replication; Ethylamines; Hepatocytes; Humans; Hydroxyquinolines; Iron Chelating Agents; Ornithine Decarboxylase; RNA, Messenger; Triazoles | 2006 |
Modulation of cell proliferation in rat liver cell cultures by new calix[4]arenes.
Topics: Animals; Benzoates; Calixarenes; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Deferasirox; Drug Screening Assays, Antitumor; Hydroxyl Radical; Iron Chelating Agents; Molecular Structure; Phenols; Rats; Solubility; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 2006 |
Antiproliferative and apoptotic effects in rat and human hepatoma cell cultures of the orally active iron chelator ICL670 compared to CP20: a possible relationship with polyamine metabolism.
Topics: Animals; Apoptosis; Base Sequence; Benzoates; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemotherapy, Adjuvant; Deferasirox; Deferiprone; DNA Primers; DNA Replication; Humans; Iron Chelating Agents; Liver Neoplasms; Liver Neoplasms, Experimental; Polyamines; Pyridones; Rats; Triazoles | 2007 |
A novel benzotriazole derivative inhibits proliferation of human hepatocarcinoma cells by increasing oxidative stress concomitant mitochondrial damage.
Topics: Antineoplastic Agents; Antioxidants; Ascorbic Acid; Carcinoma, Hepatocellular; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclosporine; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Liver Neoplasms; Membrane Potential, Mitochondrial; Mitochondria, Liver; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Oxidative Stress; Reactive Oxygen Species; Time Factors; Triazoles | 2008 |
Inhibitors of aromatase prevent degradation of the enzyme in cultured human tumour cells.
Topics: Androstenedione; Aromatase; Aromatase Inhibitors; Carcinoma, Hepatocellular; Choriocarcinoma; Colforsin; Cycloheximide; Enzyme-Linked Immunosorbent Assay; Fadrozole; Humans; Liver Neoplasms; Neoplasm Proteins; Protein Synthesis Inhibitors; RNA, Messenger; Triazoles; Tumor Cells, Cultured | 1998 |
Adenosine A(2A) and A(2B) receptor activation of erythropoietin production.
Topics: Adenosine; Alkaloids; Benzophenanthridines; Carcinoma, Hepatocellular; Enzyme Activation; Erythropoietin; Humans; Liver Neoplasms; Phenanthridines; Phenethylamines; Protein Kinase C; Purinergic P1 Receptor Antagonists; Pyrimidines; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptors, Purinergic P1; RNA, Messenger; Triazoles; Tumor Cells, Cultured; Xanthines | 2001 |
The roles of synthesis and degradation in the regulation of catalase levels in the neoplastic tissues.
Topics: Animals; Carcinoma, Hepatocellular; Catalase; Cell Membrane Permeability; Hydrogen; Kinetics; Liver; Liver Neoplasms; Mice; Microscopy, Electron; Neoplasms, Experimental; Peroxidases; Triazoles | 1969 |
[Morphologic characteristics of spontaneous tumors and leukoses in 1st generation C47B1XCBA hybrid mice].
Topics: Adenoma; Animals; Carcinogens; Carcinoma, Hepatocellular; Leukemia, Experimental; Liver; Liver Neoplasms; Lung; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Mice; Neoplasms, Experimental; Triazoles | 1969 |
Studies on rat liver catalase. V. Incorporation of 14 C-leucine into catalase by isolated rat liver ribosomes.
Topics: Acetamides; Animals; Carbon Isotopes; Carcinoma, Hepatocellular; Catalase; Cell-Free System; Cycloheximide; Dactinomycin; Depression, Chemical; In Vitro Techniques; Leucine; Liver; Liver Neoplasms; Male; Neoplasms, Experimental; Nucleotides; Puromycin; Rats; Ribonucleases; Ribosomes; Triazoles | 1971 |